Trial Profile

A Phase 1/2, Single-Blinded Trial to Evaluate the Safety and Efficacy of Intra-Articular (IA) Injection of XytriX in Adult Subjects With Grade I-IV Knee Osteoarthritis (KOA)

Status: Not yet recruiting

Phase of Trial: Phase I/II

Latest Information Update: 07 May 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

13 Apr 2026 Given protocol has been amended as above-1)Planned number of patients has been changed from 50 to 75. 2)Number of treatment arms has been changed from 1 to 3. 3) Study design such as single blind, randomization and parallel has been implemented. 4)Time frames of primary endpoints has been changed from 6 months to 24 months.
13 Apr 2026 Planned number of patients changed from 50 to 75.
13 Apr 2026 Planned End Date changed from 1 Dec 2027 to 1 Dec 2028.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com